HOPA 2018 | There will be drugs: lessons from lung cancer’s therapeutic oil boom

With the recent revolution of drugs for the treatment of lung cancer, particularly non-small cell lung cancer (NSCLC), what lessons can be learned? Here, speaking at the 2018 Hematology/Oncology Pharmacy Association (HOPA) Annual Conference in Denver, CO, Ross Camidge, MD, PhD, of University of Colorado, Aurora, CO, provides a brief overview of his presentation from the John G. Kuhn Keynote Lecture, ”There will be drugs”: lessons from lung cancer’s therapeutic oil boom.